— NMOSD is a devastating autoimmune disease of severe and recurrent central nervous system attacks which can result in blindness, paralysis and death — — UPLIZNA is indicated as monotherapy… Read More
Ottawa — For the second consecutive year, BioTalent Canada has been honoured with the recognition of being named one of the Best Workplaces™ in Canada – this year, ranking #20… Read More
TORONTO, ON. – We are thrilled to announce that Kelly Martin, LifeLabs’ Chief Financial Officer, has been awarded a 2022 Report on Business Best Executive Award. The Globe and Mail’s Report… Read More
Across the two pivotal trials, RINVOQ delivered rapid and meaningful disease control with nearly half of ankylosing spondylitis (AS) patients achieving ASAS40 (51% and 44.5% with RINVOQ versus 26% and 18.2% with… Read More
To solve complex problems such as the global pandemic or climate change, society looks to science for solutions. Academic scientists play a central role in the production and translation of… Read More
